Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Orlando Plastic Surgery Center Launches Orlando Weight Loss Program

(EMAILWIRE.COM, January 26, 2012 ) Orlando, FL -- Shockingly, a total of 68.3% of the U.S. adult population over the age of 20 has significant issues with weight! According to the Centers for Disease Control and Prevention, 33.9% of all U.S. adults over the age of 20 are obese, while 34.4% are overweight!

Also, in 2010, usage of fat tissue fillers rose 14% compared to 2009 (American Society of Plastic Surgeons).

Recognizing these startling facts, Orlando Plastic Surgery Center has launched its new Orlando Weight Loss Program.

But, Orlando Plastic Surgery Center does not advocate for individuals to lose as much weight as possible just to look good. Rather, it encourages individuals to lose weight at a healthy pace.

The Orlando Weight Loss Program helps individuals by creating a weight loss plan customized specifically to their unique needs, medically supervises the entire process, and helps individuals look and feel their best from the inside out. And best of all, this is done in a healthy and medically safe way.

“They trust our expertise and opinions, and we take that very seriously as cosmetic and plastic surgery professionals,” said lead surgeon and owner Dr. George Pope.

Orlando Plastic Surgery Center continues to demonstrate its commitment to helping people look and feel their best. It has already helped many patients improve their satisfaction with their lives. Adding a monitored and medically safe weight loss program to its repertoire of services is just one more way it is looking to help the general public.

About Orlando Plastic Surgery Center: Orlando Plastic Surgery Center is regarded as one of Central Florida’s premier plastic surgery centers. Dr. George Pope is one of Central Florida’s most sought-after plastic surgeons (he was voted to the city’s list of best plastic surgeon by readers of Orlando Magazine three years in a row). Services range from Orlando rhinoplasty and nasal contouring, breast augmentation, eyelid surgery / blepharoplasty, revisionist surgery, and Orlando gynecomastia. Liposuction and tummy tuck surgeries are also offered. Dr. Pope and his staff also provide minimally invasive procedures such as laser skin resurfacing, Sculptra Aesthetics, Botox ® injections, Latisse, Juvederm, and Restylane®. Visit orlandoplasticsurgerycenter.com for more information and to read the company’s blog. Orlando Plastic Surgery Center can also be followed on Twitter and “liked” on Facebook.
 

Press Release Courtesy of Online PR Media: http://bit.ly/xqBSD9

Orlando Plastic Surgery Center
Dee Brandt
(407) 857-6261
dbrandt@orlandoplasticsurgerycenter.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Britain's Cameron urges G7 to help reduce antibiotics use
27 May 2016 at 12:12am

ISE-SHIMA, Japan (Reuters) - British Prime Minister David Cameron urged leaders of the G7 industrial powers on Friday to do more to reduce the use of antibiotics and to reward drug companies for developing new medicines to fight drug-resistant superbug infections. "In too many cases antibiotics have stopped working, that means people are dying of simple infections or conditions like TB (tuberculosis), tetanus, sepsis, infections that should not mean a death sentence," he told a news conference at a summit in Japan. ...


British PM Cameron says happy to meet Trump but no dates fixed
26 May 2016 at 11:54pm
ISE-SHIMA, Japan (Reuters) - Prime Minister David Cameron said on Friday that no dates had been fixed for a potential visit by Donald Trump to Britain but that he would be happy to meet the presumptive Republican presidential nominee if he did visit. "Often these candidates chose to come through various European countries in the run up to the U.S. elections. No dates are fixed but I am always happy to meet people on that basis," Cameron told reporters at the G7.

Cameron says happy to meet Trump but no dates fixed
26 May 2016 at 11:49pm
ISE-SHIMA, Japan (Reuters) - Prime Minister David Cameron said on Friday that no dates had been fixed for a potential visit by Donald Trump to Britain but that he would be happy to meet the presumptive Republican presidential nominee if he did visit. "Often these candidates chose to come through various European countries in the run up to the U.S. elections. No dates are fixed but I am always happy to meet people on that basis," Cameron told reporters at the G7.


Cameron urges G7 to help reduce antibiotics use
26 May 2016 at 11:47pm

ISE-SHIMA, Japan (Reuters) - British Prime Minister David Cameron urged leaders of the G7 industrial powers on Friday to do more to reduce the use of antibiotics and to reward drug companies for developing new medicines to fight drug-resistant superbug infections. "In too many cases antibiotics have stopped working, that means people are dying of simple infections or conditions like TB (tuberculosis), tetanus, sepsis, infections that should not mean a death sentence," he told a news conference at a summit in Japan. ...


Factbox: Hiroshima survivor - Obama apology would ease my suffering
26 May 2016 at 11:45pm
By Minami Funakoshi HIROSHIMA (Reuters) - Barack Obama, the first sitting U.S. president to visit Hiroshima, will lay a wreath on Friday at the site of the world's first atomic bombing, which killed thousands instantly. Following are comments from people in Hiroshima, which was devastated on Aug. 6, 1945. "If Obama apologized, I could die and meet my parents in heaven in peace.


AstraZeneca potassium drug delayed by manufacturing snag
26 May 2016 at 11:38pm

AstraZeneca said on Friday U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a blow to a product acquired when it bought ZS Pharma for $2.7 billion last year. The British drugmaker said the Food and Drug Administration (FDA) had issued a so-called complete response letter (CRL) for ZS-9, or sodium zirconium cyclosilicate. "The CRL refers to observations arising from a pre-approval manufacturing inspection," AstraZeneca said.



Roche announces positive results for Gazyva in phase III study
26 May 2016 at 10:27pm

Roche Holding AG said on Friday its drug Gazyva showed superior progression-free survival compared to Mabthera/Rituxan in people with previously untreated follicular lymphoma in the pivotal phase III Gallium study that met is primary endpoint early. Results from an interim analysis showed that the Gazyva-based treatment significantly reduced the risk of the disease worsening or death compared to the MabThera/Rituxan-based treatment, Roche said in a statement. Follicular lymphoma is considered incurable and relapse is common.



Valeant rejected joint takeover bid from Takeda, TPG in spring: source
26 May 2016 at 8:32pm

Valeant Pharmaceuticals International Inc received a joint takeover offer from Japan's Takeda Pharmaceutical Co Ltd and TPG Capital Management LP [TPG.UL] this spring that the Canadian drugmaker rejected, according to a source familiar with the matter. The offer was made a few weeks before Joseph Papa took over as Valeant's new chief executive in April last week, the source told Reuters. Takeda and private equity firm TPG were ready to offer a substantial premium to Valeant, whose stock had fallen about 65 percent this year up to the close of trade on April 22 as the drugmaker was not just seeking a new head but was also hit by an accounting scandal, the source added.



China regulator to launch drug pricing probe in June
26 May 2016 at 7:44pm

China will carry out wide-ranging pricing inspections on drug firms, hospitals and procurement bodies from June 1, the country's top watchdog said on Friday, extending a tough cost-cutting campaign to reduce the price of healthcare. The National Development and Reform Commission (NDRC) said in a statement it would carry out the probes from June 1 until the end of October, checking the "pricing behavior" of drug firms and related institutions. Local media reported earlier this month that China was planning to launch "large-scale and systematic" anti-trust investigation into foreign and local drug firms.


The Color Purple: Biological, Sorority, and Lupy Sisters
26 May 2016 at 6:27pm
"I think it pisses God off if you walk by the color purple in a field somewhere and don't notice it." -Shug Avery in the Color PurpleIt's likely that Alice Walker wasn't thinking about Takisha Mundy and Amy Meachum when she sat down to write her award winning novel, "The Color Purple." Takisha was just beginning elementary school while Amy...

Theranos sued over blood tests, in proposed class action
26 May 2016 at 5:47pm
(Reuters) - Blood-testing company Theranos Inc was sued on Thursday, accused of endangering customer health through "massive failures" that misrepresented the accuracy and quality of its blood tests, according to court papers. The proposed class action was brought in the U.S. District Court for the Northern District of California by the law firm Hagens Berman Sobol Shapiro LLP. It estimated that thousands of consumers could be eligible to join the lawsuit, citing Theranos? claims that it had performed more than 6 million tests.


U.S. sees first case of bacteria resistant to all antibiotics
26 May 2016 at 5:35pm

U.S. health officials on Thursday reported the first case in the country of a patient with an infection resistant to all known antibiotics, and expressed grave concern that the superbug could pose serious danger for routine infections if it spreads. "We risk being in a post-antibiotic world," said Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, referring to the urinary tract infection of a 49-year-old Pennsylvania woman who had not travelled within the prior five months. Frieden, speaking at a National Press Club luncheon in Washington, D.C., said the infection was not controlled even by colistin, an antibiotic that is reserved for use against "nightmare bacteria." The infection was reported Thursday in a study appearing in Antimicrobial Agents and Chemotherapy, a publication of the American Society for Microbiology.


At G7, Britain presses for global reward system for new antibiotics
26 May 2016 at 4:06pm
By Kylie MacLellan ISE-SHIMA, Japan (Reuters) - Britain is pushing for a global plan to reward drugs companies for developing new antibiotics, while also pledging to cut antibiotic use in England. Former Goldman Sachs chief economist Jim O'Neill, who led the review, said a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market. British Prime Minister David Cameron will say at the G7 meeting in Japan on Friday that Britain will work with global finance and health experts to develop such as system to bring the new antibiotics to market and make them available to all who need them.


Report: 1st US case of germ resistant to last resort drug
26 May 2016 at 4:03pm

NEW YORK (AP) ? For the first time, a U.S. patient has been infected with bacteria resistant to an antibiotic used as a last resort treatment, scientists said Thursday.



Trump, Sanders explore an unconventional presidential debate
26 May 2016 at 3:15pm

By Emily Stephenson BISMARCK, N.D. (Reuters) - Republican Donald Trump and Democrat Bernie Sanders on Thursday explored staging an unconventional U.S. presidential debate that would sideline Democratic front-runner Hillary Clinton but create a high-ratings television spectacle. The two men - a billionaire and a democratic socialist - expressed interest in a one-on-one encounter in California even though Republican and Democratic presidential candidates traditionally do not debate each other until the parties have selected their nominees. "I'd love to debate Bernie," Trump told reporters in North Dakota, after he secured enough delegates to clinch the Republican presidential nomination.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC